CYN 154806 TFA
目录号: PL11413 纯度: ≥99%
CAS No. :2828432-46-6
商品编号 规格 价格 会员价 是否有货 数量
PL11413-1mg 1mg ¥2225.45 请登录
PL11413-5mg 5mg ¥7170.91 请登录
PL11413-10mg 10mg ¥12116.36 请登录
PL11413-50mg 50mg 询价 询价
PL11413-100mg 100mg 询价 询价
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
中文名称
CYN 154806 TFA
中文别名
(4R,7S,10S,13R,16S,19S)-13-((1H-吲哚-3-基)甲基)-19-((S)-2-乙酰氨基-3-(4-硝基苯基)丙酰胺基)-N-((R)-1-氨基-3-(4-羟基苯基)-1-氧代丙烷-2-基)-10-(4-氨基丁基)-16-(4-羟基苄基)-7-((R)-1-羟乙基)-6,9,12,15,18-五氧代-1,2-二硫杂-5,8,11,14,17-五氮杂环二十烷-4-羧酰胺三氟乙酸盐
英文名称
CYN 154806 TFA
英文别名
Cyn 154806 trifluoroacetate
Cas No.
2828432-46-6
分子式
C58H69F3N12O16S2
分子量
1311.37
包装储存
Sealed storage, away from moisturePowder -80°C 2 years;-20°C 1 year
产品详情
CYN 154806 TFA 是一种环状八肽,是一种强效的,选择性生长抑素 sst2 受体的拮抗剂,其对人重组 sst2、sst1、sst3、sst4 和 sst5 受体的 pIC50 值分别为 8.58、5.41、6.07、5.76 和 6.48。
生物活性
CYN 154806 TFA, a cyclic octapeptide, is a potent and selective somatostatin sst2 receptor antagonist, with pIC 50 values of 8.58, 5.41, 6.07, 5.76 and 6.48 for human recombinant sst2, sst1, sst3, sst4 and sst5 receptors respectively.
性状
Solid
IC50 & Target[1][2]
SSTR2
体外研究(In Vitro)
CYN 154806 TFA inhibits SRIF-induced increases in extracellular acidification (EAR) in CHO-K1 cells expressing human sst2 receptors (pKB 7.92). CYN 154806 TFA also blocks SRIF-induced increases [35S]-GTPγS binding in CHO-K1 cell membranes expressing human sst2 receptors as well as rat sst2(a) and rat sst2(b) receptors (pKB 7.81, 7.68 and 7.96, respectively). has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)
CYN 154806 TFA (0.1 mg/kg; i.p.; 20 min before the administration of carbachol (CCh) (30 μg/kg) in M4 KO mice) dose-dependently and significantly reverses the decreases acid response to CCh in M4 but not M3 KO mice. has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Sealed storage, away from moisturePowder -80°C 2 years;-20°C 1 year
SequenceShortening
Ac-F(4-NO2)CYWKTCY-NH2 (Disulfide bridge: Cys2-Cys7)
Sequence
Ac-Phe(4-NO2)-Cys-Tyr-Trp-Lys-Thr-Cys-Tyr-NH2 (Disulfide bridge: Cys2-Cys7)
参考文献
[1]. Bass RT, et al. Identification and characterization of novel somatostatin antagonists. Mol Pharmacol. 1996 Oct;50(4):709-15.
[2]. Feniuk W, et al. Selective somatostatin sst(2) receptor blockade with the novel cyclic octapeptide, CYN-154806. Neuropharmacology. 2000 Jun 8;39(8):1443-50.
[3]. Takeuchi K, et al. A
溶解度数据
In Vitro: H2O : 25 mg/mL (19.06 mM; Need ultrasonic)配制储备液
搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2